¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"dissociation factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
competence factor
1. ¸é¿ª°¡´ÉÀÎÀÚ 2. ¹ÝÀÀ°¡´ÉÀÎÀÚ
competence inducing factor
¸é¿ª°¡´ÉÀ¯¹ßÀÎÀÚ
complementary factor
º¸ÃæÀÎÀÚ
conglutinogen activating factor
±³Âø¿øÈ°¼ºÀÎÀÚ
conversion factor
º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
carcinogenic factor
¹ß¾ÏÀÎÀÚ
corticotropin-releasing factor
ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
chemotactic factor
ÈÇнò¸²ÀÎÀÚ
drug resistance factor
¾àÁ¦ÀúÇ×ÀÎÀÚ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢º´À¯¹ßÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
dilution factor
Èñ¼®ÀÎÀÚ
exclusion of confounding factor
±³¶õ¹èÁ¦ÀÎÀÚ
exogenous factor
¿ÜÀοä¼Ò
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
coagulation factor inhibitor
ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
colony-stimulating factor
Áý¶ôÀÚ±ØÀÎÀÚ
common factor
°øÅëÀÎÀÚ
competence factor
Àû°ÝÀÎÀÚ
competence inducing factor
Àû°ÝÀ¯¹ßÀÎÀÚ
complementary factor
º¸ÃæÀÎÀÚ, º¸Ã¼ÀÎÀÚ
conglutinogen activating factor
±³Âø¿øÈ°¼ºÀÎÀÚ
conversion factor
º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
corticotropin releasing factor
ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢À¯¹ßÀÎÀÚ
dilution factor
¹±ÈûÀÎÀÚ, Èñ¼®ÀÎÀÚ
drug resistance factor
¾àÁ¦ÀúÇ×ÀÎÀÚ
elongation factor
´ÃÀÓÀÎÀÚ, ¿¬ÀåÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
G-CSF (Granulocyte colony-stimulating factor)
°ú¸³¼¼Æ÷±ºÃËÁøÀÎÀÚ(Î¨Ø£á¬øàÏØõµòäì×í)
GH releasing factor
¼ºÀå(à÷íþ)È£¸£¸ó À¯¸®ÀÎÀÚ(ë´×îì×í).
GH releasing factor
¼ºÀåÈ£¸£¸óÀ¯¸®ÀÎÀÚ.
Growth factor
¼ºÀåÀÎÀÚ(à÷íþì×í)
Hageman factor
ÇϰԸ¸ÀÎÀÚ
Hydrostatic factor
Á¤¼öÀÎÀÚ(ð¡â©ì×í)
IGF-I(insulin-like growth factor-I)
Àν¶¸° À¯»ç ¼ºÀåÀÎÀÚ-1
Luteinization -inhibiting factor
ȲüȾïÁ¦¿äÀÎ(üÜô÷ûùåäð¤é©ì×)
Macrophage colony-stimulating factor
´ë½Ä¼¼Æ÷Áý¶ôÇü¼ºÃËÁøÀÎÀÚ(ÓÞãÝá¬øàó¢Õªû¡à÷õµòäì×í)à÷õµòäì×?
NGF=>nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
PAF =platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ.
PAF= platelet activating factor
Ç÷¼ÒÆÇ Ȱ¼ºÀÎÀÚ.
Q factor
Å¥ ÀÎÀÚ
Q-factor
Å¥-ÀÎÀÚ (ì×í)
R factor
³»¼ºÀÎÀÚ.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
oxyhemoglobin dissociation curve
»êÈÇì¸ð±Û·ÎºóÇØ¸®°î¼±
pupillary light-near dissociation
µ¿°ø´ë±¤-±ÙÁ¢¹Ý»çÇØ¸®
renal dissociation jaundice
½ÅÇØ¸®¼º Ȳ´Þ(ãìú°ìÆàõüÜÓ¸).
renal dissociation jaundice
½ÅÇØ¸®¼º Ȳ´Þ(ãìú°ìÆàõüÜÓ¸)
segmental sensory loss =s. s. dissociation
Áö°¢Çظ®(ò±ÊÆú°ìÆ).
segmental sensory loss =s. s. dissociation
Áö°¢Çظ®(ò±ÊÆú°ìÆ)
sensory dissociation
°¨°¢<Áö°¢>ÇØ¸® (¡ú°ìÆ).
sensory dissociation
°¨°¢<Áö°¢>ÇØ¸® (¡ú°ìÆ)
syringomyelic dissociation
ô¼ö°øµ¿Áõ¼º Áö°¢Çظ®(ô±âÐÍö÷Óñøàõò±ÊÆú°ìÆ).
syringomyelic dissociation
ô¼ö°øµ¿Áõ¼º Áö°¢Çظ®(ô±âÐÍö÷Óñøàõò±ÊÆú°ìÆ)
thermal dissociation
¿Çظ®(æðú°ìÆ).
ventriculoatrial dissociation
½Ç¹æÇظ®.
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
age factor
¿¬·ÉÀÎÀÚ.
air kerma calibration factor
°ø±âÄ¿¸¶ÃøÁ¤°è¼ö, -´«±Ý¸ÂÃã°è¼ö
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½